Internal Medicine Alert - August 30, 2008

Target Audience:

This activity is intended for the internist and family practitioner.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Executive Editor
Stephen A. Brunton, MD

Clinical Professor
University of California, Irvine

Associate Editors
Mary Elina Ferris, MD
Clinical Associate Professor
University of Southern California

Joseph Varon, MD, FACP, FCCP, FCCM
Clinical Professor of Internal Medicine
University of Texas Health Science Center
Adjunct Professor of Medicine
University Texas Medical Branch

Barbara A. Phillips, MD, MSPH

Professor of Medicine
University of Kentucky;
Director, Sleep Disorders Center
Samaritan Hospital

William T. Elliott, MD, FACP
Chair, Formulary Committee
Northern California Kaiser Permanente
Asst. Clinical Professor of Medicine
University of California
San Francisco

James Chan, PharmD, PhD
Pharmacy Quality and Outcomes Manager
Kaiser Permanente
Oakland, CA

Louis Kuritzky, MD
Clinical Assistant Professor
University of Florida

F. Tuna Burgut, MD
Assistant Professor of Neurology and Psychiatry
Weill Cornell Medical College
New York Presbyterian Hospital

Peer Reviewer
Gerald Roberts, MD
Assistant Clinical Professor of Medicine
Albert Einstein College of Medicine
New York, NY


  • Motivating Women to Use Supplemental Calcium
  • How Often Does Mild Cognitive Impairment Progress to Alzheimer's Disease?
  • How Often Does Mild Cognitive Impairment Progress to Alzheimer's Disease?
  • How Important IS Sex, Anyway?
  • Aliskiren and Hydrochlorothiazide Tablets (Tektura┬«HCT)
  • Clinical Briefs by Louis Kuritzky, MD


  • describe new findings in differential diagnosis and treatment of various diseases
  • describe controversies, advantages, and disadvantages of those advances
  • describe cost-effective treatment regimens
  • describe the pros and cons of new screening procedures.

Financial Disclosure:

Internal Medicine Alert's editor, Stephen Brunton, MD, is a consultant for Abbott, Amylin, Boehringer Ingelheim, Eli Lilly, Endo, Novartis, and Novo Nordisk. Peer reviewer Gerald Roberts, MD, reports no financial relationship to this field of study. Associate editors Mary Elina Ferris, MD, Joseph Varon, MD, FACP, FCCP, FCCM, Barbara A. Phillips, MD, MSPH, William T. Elliott, MD, FACP, James Chan, PharmD, PhD, author F. Tuna Burgut, MD, and peer reviewer Gerald Roberts, MD, report no financial relationship to this field of study. Louis Kuritzky, MD is a consultant for GlaxoSmithKline and is on the speaker's bureau of GlaxoSmithKline, 3M, Wyeth-Ayerst, Pfizer, Novartis, Bristol-Myers Squibb, AstraZeneca, Jones Pharma, and Boehringer Ingelheim.

Copyright 2008 AHC Media. All rights reserved.